Protective major histocompatibility complex allele prevents type 1 diabetes by shaping the intestinal microbiota early in ontogeny.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28831005)

Published in Proc Natl Acad Sci U S A on August 22, 2017

Authors

Michael Silverman1,2, Lindsay Kua1, Alessandro Tanca3, Mauro Pala4, Antonio Palomba3, Ceylan Tanes5, Kyle Bittinger5, Sergio Uzzau3,6, Christophe Benoist7,8, Diane Mathis7,8

Author Affiliations

1: Division of Immunology, Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA 02115.
2: Division of Infectious Diseases, Department of Medicine, Boston Children's Hospital, Boston, MA 02115.
3: Porto Conte Ricerche, Tramariglio, 07041 Alghero (SS), Italy.
4: Istituto di Ricerca Genetica e Biomedica, Consiglio Nazionale delle Ricerche, 09042 Monserrato (CA), Italy.
5: Division of Gastroenterology, Hepatology, and Nutrition, The Children's Hospital of Philadelphia, Philadelphia, PA 19104.
6: Dipartimento di Scienze Biomediche, Università di Sassari, 07100 Sassari, Italy.
7: Division of Immunology, Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA 02115; cbdm@hms.harvard.edu.
8: Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA 02115.

Articles cited by this

QIIME allows analysis of high-throughput community sequencing data. Nat Methods (2010) 85.34

Generalized linear mixed models: a practical guide for ecology and evolution. Trends Ecol Evol (2009) 28.00

Universal sample preparation method for proteome analysis. Nat Methods (2009) 16.88

Metagenomic biomarker discovery and explanation. Genome Biol (2011) 11.29

The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med (2002) 9.26

The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe (2014) 7.43

IgA response to symbiotic bacteria as a mediator of gut homeostasis. Cell Host Microbe (2007) 5.18

Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease. Cell (2014) 4.25

Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes. J Exp Med (1999) 3.85

Naturally transmitted segmented filamentous bacteria segregate with diabetes protection in nonobese diabetic mice. Proc Natl Acad Sci U S A (2011) 3.55

Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria. Nature (2013) 3.21

Physiological beta cell death triggers priming of self-reactive T cells by dendritic cells in a type-1 diabetes model. J Exp Med (2003) 2.94

Several mechanisms can account for defective E alpha gene expression in different mouse haplotypes. Proc Natl Acad Sci U S A (1983) 2.84

The "perfect storm" for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes (2008) 2.77

The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes. Cell Host Microbe (2015) 2.58

Interleukin 23 production by intestinal CD103(+)CD11b(+) dendritic cells in response to bacterial flagellin enhances mucosal innate immune defense. Immunity (2012) 2.54

Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice. Nat Med (2002) 2.29

Differences in risk of insulin-dependent diabetes in offspring of diabetic mothers and diabetic fathers. N Engl J Med (1984) 2.26

Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A beta-chain or normal I-E alpha-chain. Nature (1990) 2.23

Dominant protection from HLA-linked autoimmunity by antigen-specific regulatory T cells. Nature (2017) 2.06

Endocrine self and gut non-self intersect in the pancreatic lymph nodes. Proc Natl Acad Sci U S A (2005) 2.06

Prevention of autoimmune insulitis by expression of I-E molecules in NOD mice. Nature (1987) 2.04

Pancreatic lymph nodes are required for priming of beta cell reactive T cells in NOD mice. J Exp Med (2002) 2.02

An explanation for the protective effect of the MHC class II I-E molecule in murine diabetes. Nature (1989) 1.97

Rapid fucosylation of intestinal epithelium sustains host-commensal symbiosis in sickness. Nature (2014) 1.78

Genetic protection from the inflammatory disease type 1 diabetes in humans and animal models. Immunity (2001) 1.72

MHC-linked protection from diabetes dissociated from clonal deletion of T cells. Science (1990) 1.70

Influence of microbial environment on autoimmunity. Nat Immunol (2009) 1.59

Microbial community analysis using MEGAN. Methods Enzymol (2013) 1.55

Loss of sex and age driven differences in the gut microbiome characterize arthritis-susceptible 0401 mice but not arthritis-resistant 0402 mice. PLoS One (2012) 1.42

T cell receptor V gene usage of islet beta cell-reactive T cells is not restricted in non-obese diabetic mice. J Exp Med (1991) 1.40

Comparison of detergent-based sample preparation workflows for LTQ-Orbitrap analysis of the Escherichia coli proteome. Proteomics (2013) 1.40

Genetics of the HLA region in the prediction of type 1 diabetes. Curr Diab Rep (2011) 1.30

Genetic determination of islet cell autoimmunity in monozygotic twin, dizygotic twin, and non-twin siblings of patients with type 1 diabetes: prospective twin study. BMJ (1999) 1.23

The influence of the microbiota on type-1 diabetes: on the threshold of a leap forward in our understanding. Immunol Rev (2012) 1.13

A straightforward and efficient analytical pipeline for metaproteome characterization. Microbiome (2014) 1.08

Antimicrobial defense of the intestine. Immunity (2015) 1.08

Enrichment or depletion? The impact of stool pretreatment on metaproteomic characterization of the human gut microbiota. Proteomics (2015) 0.95

The effect of bone marrow and thymus chimerism between non-obese diabetic (NOD) and NOD-E transgenic mice, on the expression and prevention of diabetes. Eur J Immunol (1993) 0.89

Gut microbial markers are associated with diabetes onset, regulatory imbalance, and IFN-γ level in NOD mice. Gut Microbes (2015) 0.86

The bilateral responsiveness between intestinal microbes and IgA. Trends Immunol (2015) 0.85

MHC variation sculpts individualized microbial communities that control susceptibility to enteric infection. Nat Commun (2015) 0.85

Inhibition of autoimmune diabetes in nonobese diabetic mice by transgenic restoration of H2-E MHC class II expression: additive, but unequal, involvement of multiple APC subtypes. J Immunol (2001) 0.81

Both central and peripheral tolerance mechanisms play roles in diabetes prevention in NOD-E transgenic mice. Autoimmunity (2008) 0.80

Dendritic cell-dependent in vivo generation of autoregulatory T cells by antidiabetogenic MHC class II. J Immunol (2013) 0.80

IL-12 administration reveals diabetogenic T cells in genetically resistant I-Ealpha-transgenic nonobese diabetic mice: resistance to autoimmune diabetes is associated with binding of Ealpha-derived peptides to the I-A(g7) molecule. J Immunol (2001) 0.79

The Influence of the Autoimmunity-Associated Ancestral HLA Haplotype AH8.1 on the Human Gut Microbiota: A Cross-Sectional Study. PLoS One (2015) 0.76